Introduction
============

Cancer has been the leading cause of death in Korea since 1983 \[[@b1-crt-2015-060]\] and is the most burdensome disease \[[@b2-crt-2015-060]\]. More than 210,000 new cancer cases are diagnosed in Korea each year, and cancer is responsible for one in four deaths \[[@b3-crt-2015-060]\]. This article reports the most recent nationwide cancer statistics in Korea, including incidence, mortality, survival, prevalence, and their trends.

1. Data sources
---------------

The Ministry of Health and Welfare, Korea, initiated a nationwide hospital-based cancer registry called the Korea Central Cancer Registry (KCCR) in 1980. The registry collected 80%-90% of cancer cases annually from more than 180 training hospitals throughout the country.

In 1999, the KCCR expanded cancer registration to cover the entire population under the Population-Based Regional Cancer Registry Program. Details of the history, objectives, and activities of the KCCR have been documented elsewhere \[[@b4-crt-2015-060]\]. Incidence data for 1999-2012 were obtained from the Korea National Cancer Incidence Database (KNCI DB). The completeness of incidence data for 2012 was 97.7%, as determined by the Ajiki method \[[@b5-crt-2015-060]\].

Cancer cases were classified according to the International Classification of Diseases for Oncology, third edition \[[@b6-crt-2015-060]\] and converted according to the International Classification of Diseases, 10th edition (ICD-10) \[[@b7-crt-2015-060]\]. A total of 2,405,894 cancer cases first diagnosed between 1993 and 2012 from the KNCI DB were used in the survival analysis, and vital status was followed until December 31, 2013.

Mortality data from 1983 to 2012 were obtained from Statistics Korea \[[@b1-crt-2015-060]\]. Cause of death was coded and classified according to ICD-10 \[[@b7-crt-2015-060]\]. Population data were also obtained from Statistics Korea using the resident registration population on July 1 of specified years.

2. Analysis
-----------

Crude rates (CRs) and age-specific rates of cancer incidence and mortality were calculated. Age-standardized rates (ASRs) were calculated using Segi's world standard population \[[@b8-crt-2015-060]\]. Cumulative risks of cancer, which represent the probability of developing cancer during one's lifetime, were also calculated. Changes in the annual ASRs of cancer incidence were examined by calculating the annual percentage change over a time period as (exp(*b*)--1)×100, where *b* is the slope of the regression of log ASR for a given calendar year \[[@b9-crt-2015-060]\].

Prevalence was also calculated for assessment of cancer burden, which includes new and pre-existing cancer patients diagnosed during a given time period who were still alive on an index date. Using the cancer incidence database data from 1999 to 2012, we defined prevalent cases as patients who were diagnosed between January 1, 1999 and December 31, 2012, and were still alive on January 1, 2013. We calculated limited-duration prevalences, namely, 1- and 5-year prevalences. For example, the 5-year prevalence was calculated as the number of people alive on January 1, 2013 who had been diagnosed with cancer within the previous 5 years. We applied this counting method using the SEER^\*^Stat software \[[@b10-crt-2015-060]\] to calculate the number of cases while adjusting for patients lost to follow-up.

The survival duration for each case was determined as the interval between the date of initial diagnosis and the date of death, date of loss to follow-up, or closing date for followup. Observed survival rates were calculated using the lifetable method and relative survival rates using the Ederer II method \[[@b11-crt-2015-060]\] were based on an algorithm written in SAS by Paul Dickman \[[@b12-crt-2015-060]\], with some minor modifications.

Selected Findings
=================

1. Incidence
------------

The overall number of incident cancer cases, deaths, and prevalent cases by sex and cancer site for 2012 in Korea are shown in [Table 1](#t1-crt-2015-060){ref-type="table"}. A total of 224,177 incident cancer cases and 73,759 deaths were reported to occur in 2012. As of January 1, 2013, 1,234,879 prevalent cancer cases diagnosed between 1999 and 2012 were identified. The cumulative risk of developing cancer during one's lifetime in 2012 was 37.5% for males and 34.9% for females.

The cancer incidence rates in 2012 by sex and cancer site are shown in [Table 2](#t2-crt-2015-060){ref-type="table"}. The 2012 CRs per 100,000 of all sites combined were 446.2 and 444.4 for males and females, respectively. The ASRs per 100,000 of all sites combined were 326.4 and 290.1 for males and females, respectively. In males, the five leading primary cancer sites were stomach (CR, 82.7; ASR, 59.3), colon and rectum (CR, 69.3; ASR, 50.0), lung (CR, 61.0; ASR, 44.3), liver (CR, 48.2; ASR, 34.3), and prostate (CR, 36.8; ASR, 27.0), which together accounted for 66.8% of all newly diagnosed cancers in 2012. In females, the most common cancer site was thyroid (CR, 142.9; ASR, 102.4), followed by breast (CR, 65.7; ASR, 44.7), colon and rectum (CR, 45.9; ASR, 26.8), stomach (CR, 39.8; ASR, 23.5), and lung (CR, 26.8; ASR, 14.9), which together accounted for 72.3% of all newly diagnosed cancers. Thyroid cancer alone accounted for 32.2% of incident cases (n=35,955) among females in 2012.

2. Mortality
------------

A total of 73,759 cancer deaths were reported in Korea for 2012, accounting for 27.6% of all deaths ([Table 3](#t3-crt-2015-060){ref-type="table"}). In 2012, the CRs per 100,000 for all sites combined were 184.5 and 108.5 in males and females, respectively. The ASRs per 100,000 for all sites combined were 135.2 and 57.7 for males and females, respectively. Cancers of the lung, liver, stomach, and colon/rectum were the main causes of cancer death, together accounting for approximately 61.6% of all cancer deaths in 2012 ([Table 4](#t4-crt-2015-060){ref-type="table"}).

In males, the five most common sites of cancer death in 2012 were lung (CR, 48.3; ASR, 35.1), liver (CR, 33.7; ASR, 24.1), stomach (CR, 24.2; ASR, 17.6), colon and rectum (CR, 18.5; ASR, 13.7), and pancreas (CR, 10.4; ASR, 7.6). In women, lung cancer (CR, 17.8; ASR, 8.9) was the leading cause of cancer death in 2012, followed by colon and rectum (CR, 13.8; ASR, 6.8), stomach (CR, 12.9; ASR, 6.5), liver (CR, 11.3; ASR, 6.1), and pancreas (CR, 8.6; ASR, 4.4).

3. Trends in cancer incidence
-----------------------------

The cancer incidence rates from 1999 to 2012 in Korea for all sites combined and for selected sites are shown in [Tables 5](#t5-crt-2015-060){ref-type="table"}-[](#t6-crt-2015-060){ref-type="table"}[7](#t7-crt-2015-060){ref-type="table"}. The incidence for all sites combined increased by 3.3% per year (1.5% in males, 5.3% in females) from 1999 to 2012. The increase in cancer incidence is also illustrated in [Fig. 1](#f1-crt-2015-060){ref-type="fig"}.

The incidence rates for colorectal and thyroid cancers have continued to increase in both sexes, as have those for prostate cancer in males and breast cancer in females ([Fig. 2](#f2-crt-2015-060){ref-type="fig"}). In contrast, the incidences of liver cancer in both sexes, lung cancer in males, and cervical cancer in females have decreased. Notably, thyroid cancer increased rapidly, by 22.3% per year in both sexes, and has been the most common cancer since 2009. Improvements in the sensitivity of diagnostic techniques for thyroid cancer, such as the advent of ultrasound and fine-needle aspiration, have enabled detection of small-sized thyroid cancers, and screening rates have increased. Therefore, the increased incidence of thyroid cancer might reflect the identification of previously undetected diseases rather than a true increase in the occurrence of thyroid cancer \[[@b13-crt-2015-060]-[@b16-crt-2015-060]\]. In addition, due to the construction of a 1999-2012 KNCI DB, the completeness of the Korean cancer registry data has shown gradual improvement, and this may have contributed, in part, to the gradual overall increases in cancer incidence, particularly among elderly patients.

The incidence of some cancer sites in 2012, including stomach, colon and rectum, decreased compared to 2011. However, these trends could be causes of random error, therefore, these results should be interpreted with caution.

4. Age-specific incidence rates
-------------------------------

The most common cancer sites by sex and age group in 2012 are shown in [Table 8](#t8-crt-2015-060){ref-type="table"}. Leukemia and thyroid cancer were the most common cancer in both sexes in patients aged 0-14 and 15-34 years, respectively. For males, stomach cancer was the most common cancer in those aged 35-64, while lung cancer was more frequent among patients aged 65 and over. Thyroid cancer was the most common cancer in females aged 35-64 years, and colorectal cancer was the most common cancer among older females aged 65 and over.

The age-specific incidence rates for selected cancers in males and females in 2012 are shown in [Fig. 3](#f3-crt-2015-060){ref-type="fig"}. The graphs show that the incidences of stomach, lung, liver, and colorectal cancers increased gradually with age. Incidences of breast and thyroid cancers in females were highest among patients in their late 40s and early 50s, respectively, and leveled off thereafter. The age-specific pattern of breast cancer is different from those in Western countries \[[@b17-crt-2015-060]\].

5. Trends in cancer mortality
-----------------------------

The trends in cancer deaths for all sites combined and for selected sites are shown in [Figs. 1](#f1-crt-2015-060){ref-type="fig"} and [4](#f4-crt-2015-060){ref-type="fig"}. ASRs of mortality for all sites combined decreased by 2.7% per year in both sexes since 2002. Lung cancer surpassed stomach cancer as the leading cause of cancer death in 1999 and is expected to account for 22.6% of all cancer deaths in 2012. However, the ASRs of mortality due to lung cancer have decreased slightly in both males and females since 2002. The ASRs of mortality due to stomach and cervical cancers have also shown a continuous decrease. Along with significant increases in prostate and female breast cancer incidence rates, mortality rates of these cancers have also continued to increase.

6. Survival rates
-----------------

The trends in relative survival for all sites combined among both sexes by year of diagnosis from 1999 to 2012 are shown in [Fig. 5](#f5-crt-2015-060){ref-type="fig"}. The relative survival for all sites combined increased with year of diagnosis, and also increased when we excluded thyroid cancer cases in our analysis.

[Table 9](#t9-crt-2015-060){ref-type="table"} shows the 5-year relative survival rates for four diagnosis periods: 1993-1995, 1996-2000, 2001-2005, and 2008- 2012. The 5-year relative survival rate of patients diagnosed with cancer in the most recent period (2008-2012) was 68.1% for all sites combined in both sexes (59.6% in males and 76.6% in females). When compared with earlier periods, notable improvements in the 5-year relative survival rates were observed for all sites combined. The higher cancer survival rate in females might be explained in part by cancers common in females (e.g., thyroid and breast cancers) having relatively good prognoses.

When examined by year of diagnosis and cancer site, the 5-year relative survival rates appeared to be higher for most major cancers in patients diagnosed from 2008 to 2012 compared with those diagnosed from 1993 to 1995, with the exception of pancreatic cancer. The greatest improvements were seen in cancers of the prostate, stomach, leukemia, lip/oral cavity/pharynx, and non-Hodgkin lymphoma. The improving survival rates could be attributable to early detection and improved treatments \[[@b18-crt-2015-060],[@b19-crt-2015-060]\]; however, this requires further evaluation. Only pancreatic cancer showed no improvement in 5-year relative survival rate compared with 1993-1995. A lack of progress in early detection and treatment could explain the observed absence of improvement in the survival rate for pancreatic cancer \[[@b20-crt-2015-060]\].

7. Prevalence rates
-------------------

The cancer prevalence rates by sex and cancer site on January 1, 2013 in Korea are shown in [Table 10](#t10-crt-2015-060){ref-type="table"}. The CRs per 100,000 of cancer prevalence for all sites combined were 2,175.0 and 2,730.9 in males and females, respectively, and the ASRs per 100,000 of cancer prevalence for all sites combined were 1,592.2 and 1,788.0 in males and females, respectively. In males, the five leading primary sites of cancer for prevalence were stomach (CR, 546.5; ASR, 391.3), colon and rectum (CR, 410.9; ASR, 296.6), prostate (CR, 194.6; ASR, 141.6), thyroid (CR, 162.5; ASR, 114.8), and liver (CR, 152.6; ASR, 109.7), which together accounted for 67.4% of all prevalent cancer cases. In females, the most common cancer site was thyroid (CR, 866.0; ASR, 600.7), followed by breast (CR, 523.0; ASR, 346.7), colon and rectum (CR, 278.1; ASR, 161.8), stomach (CR, 276.2; ASR, 162.9), and cervix uteri (CR, 173.0; ASR, 111.7), which together accounted for 77.5% of all prevalent cancer cases.

The prevalence by time since diagnosis is shown in [Fig. 6](#f6-crt-2015-060){ref-type="fig"}. For all cancers combined, the 2-year prevalence constituted 29.6% of all prevalent cases. The 2-year prevalence, as a percentage of the total prevalence, was highest for thyroid (23.1%), followed by stomach (14.5%) and colon and rectum (13.8%), which had high incidence rates and good prognoses. For all cancers combined in both sexes, the 2-5-year and \> 5-year prevalences accounted for 30.5% and 39.9% of the total prevalence, respectively. The long-term prevalences for lung and liver cancers were relatively low due to low survival rates of lung and liver cancer patients.
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###### 

Cancer incidence, prevalence, and deaths by sex in Korea, 2012

  Site/Type                                                    New cases   Deaths    Prevalent cases[^a)^](#tfn2-crt-2015-060){ref-type="table-fn"}                                                    
  ------------------------------------------------------------ ----------- --------- ---------------------------------------------------------------- -------- -------- -------- ----------- --------- ---------
  All sites                                                    224,177     112,385   111,792                                                          73,759   46,462   27,297   1,234,879   547,837   687,042
  Lip, oral cavity, and pharynx                                2,913       2,135     778                                                              1,036    809      227      17,024      11,501    5,523
  Esophagus                                                    2,332       2,116     216                                                              1,398    1,278    120      7,444       6,714     730
  Stomach                                                      30,847      20,839    10,008                                                           9,342    6,090    3,252    207,145     137,655   69,490
  Colon and rectum                                             28,988      17,445    11,543                                                           8,135    4,666    3,469    173,459     103,488   69,971
  Liver                                                        16,254      12,152    4,102                                                            11,335   8,494    2,841    51,402      38,434    12,968
  Gallbladder[^b)^](#tfn3-crt-2015-060){ref-type="table-fn"}   5,131       2,600     2,531                                                            3,688    1,818    1,870    14,778      7,532     7,246
  Pancreas                                                     5,403       2,940     2,463                                                            4,778    2,616    2,162    7,032       3,803     3,229
  Larynx                                                       1,099       1,036     63                                                               412      389      23       8,600       8,076     524
  Lung                                                         22,118      15,367    6,751                                                            16,654   12,175   4,479    53,480      34,422    19,058
  Breast                                                       16,589      68        16,521                                                           2,013    20       1,993    132,139     558       131,581
  Cervix uteri                                                 3,584       \-        3,584                                                            889      \-       889      43,523      \-        43,523
  Corpus uteri                                                 1,979       \-        1,979                                                            244      \-       244      15,191      \-        15,191
  Ovary                                                        2,167       \-        2,167                                                            910      \-       910      14,171      \-        14,171
  Prostate                                                     9,258       9,258     \-                                                               1,460    1,460    \-       49,007      49,007    \-
  Testis                                                       243         243       \-                                                               13       13       \-       2,210       2,210     \-
  Kidney                                                       4,152       2,882     1,270                                                            917      663      254      26,015      17,551    8,464
  Bladder                                                      3,485       2,798     687                                                              1,221    918      303      25,497      20,754    4,743
  Brain and CNS                                                1,703       933       770                                                              1,186    619      567      8,626       4,508     4,118
  Thyroid                                                      44,007      8,052     35,955                                                           373      127      246      258,795     40,921    217,874
  Hodgkin lymphoma                                             264         177       87                                                               64       44       20       2,006       1,281     725
  Non-Hodgkin lymphoma                                         4,553       2,542     2,011                                                            1,523    920      603      26,426      14,299    12,127
  Multiple myeloma                                             1,272       696       576                                                              823      472      351      3,842       2,042     1,800
  Leukemia                                                     2,826       1,595     1,231                                                            1,666    919      747      14,890      8,216     6,674
  Other and ill-defined                                        13,010      6,511     6,499                                                            3,679    1,952    1,727    72,177      34,865    37,312

CNS, central nervous system.

Limited-duration prevalent cases on January 1, 2013; These patients who were diagnosed between January 1, 1999 and December 31, 2012 and were alive on January 1, 2013; Multiple primary cancer cases were counted multiple times,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized cancer incidence rates by sex in Korea, 2012

  Site/Type                                                    Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000[^a)^](#tfn5-crt-2015-060){ref-type="table-fn"}                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    445.3                              446.2                                                                                        444.4   299.0   326.4   290.1
  Lip, oral cavity, and pharynx                                5.8                                8.5                                                                                          3.1     3.9     6.1     2.0
  Esophagus                                                    4.6                                8.4                                                                                          0.9     3.0     6.1     0.5
  Stomach                                                      61.3                               82.7                                                                                         39.8    39.9    59.3    23.5
  Colon and rectum                                             57.6                               69.3                                                                                         45.9    37.3    50.0    26.8
  Liver                                                        32.3                               48.2                                                                                         16.3    21.1    34.3    9.5
  Gallbladder[^b)^](#tfn6-crt-2015-060){ref-type="table-fn"}   10.2                               10.3                                                                                         10.1    6.3     7.6     5.3
  Pancreas                                                     10.7                               11.7                                                                                         9.8     6.7     8.4     5.4
  Larynx                                                       2.2                                4.1                                                                                          0.3     1.4     3.0     0.1
  Lung                                                         43.9                               61.0                                                                                         26.8    27.4    44.3    14.9
  Breast                                                       33.0                               0.3                                                                                          65.7    22.6    0.2     44.7
  Cervix uteri                                                 7.1                                \-                                                                                           14.2    4.9     \-      9.5
  Corpus uteri                                                 3.9                                \-                                                                                           7.9     2.7     \-      5.3
  Ovary                                                        4.3                                \-                                                                                           8.6     3.1     \-      6.0
  Prostate                                                     18.4                               36.8                                                                                         \-      11.6    27.0    \-
  Testis                                                       0.5                                1.0                                                                                          \-      0.5     0.9     \-
  Kidney                                                       8.2                                11.4                                                                                         5.0     5.6     8.2     3.2
  Bladder                                                      6.9                                11.1                                                                                         2.7     4.3     8.1     1.4
  Brain and CNS                                                3.4                                3.7                                                                                          3.1     2.8     3.3     2.4
  Thyroid                                                      87.4                               32.0                                                                                         142.9   62.5    23.0    102.4
  Hodgkin lymphoma                                             0.5                                0.7                                                                                          0.3     0.5     0.6     0.3
  Non-Hodgkin lymphoma                                         9.0                                10.1                                                                                         8.0     6.6     7.9     5.6
  Multiple myeloma                                             2.5                                2.8                                                                                          2.3     1.6     2.0     1.4
  Leukemia                                                     5.6                                6.3                                                                                          4.9     4.9     5.9     4.1
  Other and ill-defined                                        25.8                               25.9                                                                                         25.8    17.6    20.1    15.7

CNS, central nervous system.

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The top 10 leading causes of death in Korea, 2012

  Rank   Cause of death                       No. of deaths   Percentage of all deaths   Age-standardized death rate per 100,000[^a)^](#tfn8-crt-2015-060){ref-type="table-fn"}
  ------ ------------------------------------ --------------- -------------------------- ----------------------------------------------------------------------------------------
         All causes                           267,221         100.0                      326.6
  1      Cancer                               73,759          27.6                       90.2
  2      Heart disease                        26,442          9.9                        30.7
  3      Cerebrovascular disease              25,744          9.6                        29.0
  4      Intentional self-harm (suicide)      14,160          5.3                        20.4
  5      Diabetes mellitus                    11,557          4.3                        13.2
  6      Pneumonia                            10,314          3.9                        11.4
  7      Chronic lower respiratory diseases   7,831           2.9                        8.5
  8      Disease of liver                     6,793           2.5                        8.8
  9      Transport accidents                  6,502           2.4                        9.6
  10     Hypertensive diseases                5,239           2.0                        5.8
         Others                               78,880          29.6                       99.2

Source: Mortality Data, 2012, Statistics Korea \[[@b1-crt-2015-060]\].

Age-adjusted using the world standard population.

###### 

Crude and age-standardized cancer mortality rates by sex in Korea, 2012

  Site/Type                                                     Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000[^a)^](#tfn10-crt-2015-060){ref-type="table-fn"}                          
  ------------------------------------------------------------- ---------------------------------- --------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                     146.5                              184.5                                                                                         108.5   90.2   135.2   57.7
  Lip, oral cavity, and pharynx                                 2.1                                3.2                                                                                           0.9     1.3    2.3     0.5
  Esophagus                                                     2.8                                5.1                                                                                           0.5     1.7    3.7     0.2
  Stomach                                                       18.6                               24.2                                                                                          12.9    11.2   17.6    6.5
  Colon and rectum                                              16.2                               18.5                                                                                          13.8    9.7    13.7    6.8
  Liver                                                         22.5                               33.7                                                                                          11.3    14.4   24.1    6.1
  Gallbladder[^b)^](#tfn11-crt-2015-060){ref-type="table-fn"}   7.3                                7.2                                                                                           7.4     4.3    5.3     3.6
  Pancreas                                                      9.5                                10.4                                                                                          8.6     5.8    7.6     4.4
  Larynx                                                        0.8                                1.5                                                                                           0.1     0.5    1.1     0.0
  Lung                                                          33.1                               48.3                                                                                          17.8    19.8   35.1    8.9
  Breast                                                        4.0                                0.1                                                                                           7.9     2.6    0.1     5.1
  Cervix uteri                                                  1.8                                \-                                                                                            3.5     1.1    \-      2.0
  Corpus uteri                                                  0.5                                \-                                                                                            1.0     0.3    \-      0.6
  Ovary                                                         1.8                                \-                                                                                            3.6     1.2    \-      2.2
  Prostate                                                      2.9                                5.8                                                                                           \-      1.6    4.5     \-
  Testis                                                        0.0                                0.1                                                                                           \-      0.0    0.0     \-
  Kidney                                                        1.8                                2.6                                                                                           1.0     1.1    1.9     0.5
  Bladder                                                       2.4                                3.6                                                                                           1.2     1.3    2.8     0.5
  Brain and CNS                                                 2.4                                2.5                                                                                           2.3     1.8    2.0     1.6
  Thyroid                                                       0.7                                0.5                                                                                           1.0     0.4    0.4     0.5
  Hodgkin lymphoma                                              0.1                                0.2                                                                                           0.1     0.1    0.1     0.1
  Non-Hodgkin lymphoma                                          3.0                                3.7                                                                                           2.4     1.9    2.7     1.3
  Multiple myeloma                                              1.6                                1.9                                                                                           1.4     1.0    1.4     0.8
  Leukemia                                                      3.3                                3.6                                                                                           3.0     2.4    3.0     2.0
  Other and ill-defined                                         7.3                                7.7                                                                                           6.9     4.6    5.9     3.7

CNS, central nervous system.

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates for both sexes from 1999 to 2012 in Korea

  Site/Type                                                     Year                                                                                                            
  ------------------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------------------------------------------------------
  All sites                                                     210.5   205.1   216.7   220.1   227.8   235.0   247.9   252.1   263.4   275.8   286.6   292.9   302.8   299.0   3.3[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Lip, oral cavity, and pharynx                                 3.6     4.4     3.6     3.7     3.8     3.8     3.8     3.8     3.9     4.0     3.8     4.0     4.0     3.9     0.4
  Esophagus                                                     4.1     3.7     3.9     3.8     3.6     3.6     3.5     3.4     3.3     3.3     3.1     3.1     3.0     3.0     -2.2[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Stomach                                                       43.6    42.3    44.0    43.6    43.3    41.2    44.4    42.9    41.8    42.6    43.4    42.5    42.7    39.9    -0.3
  Colon and rectum                                              20.4    21.0    22.9    24.7    26.9    28.6    31.0    32.5    33.8    34.9    36.9    36.9    38.1    37.3    5.3[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Liver                                                         27.9    26.7    27.3    26.5    25.8    25.6    25.8    24.6    24.4    24.1    23.5    22.8    22.4    21.1    -1.9[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Gallbladder[^b)^](#tfn14-crt-2015-060){ref-type="table-fn"}   6.5     6.4     6.7     6.7     6.7     6.9     7.1     6.6     6.6     6.4     6.8     6.6     6.4     6.3     -0.2
  Pancreas                                                      5.6     5.5     5.5     5.8     5.9     6.0     6.3     6.2     6.3     6.4     6.3     6.4     6.7     6.7     1.5[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Larynx                                                        2.3     2.2     2.4     2.2     2.1     1.9     2.0     1.8     1.8     1.7     1.7     1.6     1.5     1.4     -3.7[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Lung                                                          28.5    27.7    28.3    28.5    27.9    28.8    29.0    28.7    28.4    28.2    28.3    28.6    28.6    27.4    0.0
  Breast                                                        10.7    10.8    12.7    13.9    14.2    15.0    16.3    16.9    18.1    18.9    19.6    20.6    22.3    22.6    6.0[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Cervix uteri                                                  8.5     7.9     8.3     7.7     7.4     6.9     6.5     6.4     5.7     5.9     5.5     5.6     5.2     4.9     -4.2[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Corpus uteri                                                  1.4     1.3     1.5     1.7     1.9     1.9     2.0     2.1     2.2     2.4     2.6     2.6     2.7     2.7     5.6[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Ovary                                                         2.7     2.5     2.5     2.6     2.7     2.7     2.8     2.8     3.1     2.9     2.8     3.0     2.9     3.1     1.4[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Prostate                                                      3.1     2.7     3.6     3.9     4.8     6.0     6.3     7.3     8.6     9.8     10.6    11.0    11.9    11.6    13.0[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Testis                                                        0.3     0.3     0.3     0.3     0.3     0.3     0.3     0.4     0.4     0.4     0.4     0.4     0.5     0.5     4.5[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Kidney                                                        3.0     2.9     3.3     3.4     3.5     3.7     4.1     4.4     4.8     5.1     5.2     5.3     5.6     5.6     5.8[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Bladder                                                       4.6     4.6     4.9     4.7     5.1     5.1     5.1     4.9     5.0     4.8     4.6     4.7     4.6     4.3     -0.4
  Brain and CNS                                                 2.9     2.8     2.8     2.6     2.9     2.9     3.0     2.9     3.1     3.0     3.0     3.1     2.7     2.8     0.4
  Thyroid                                                       6.3     6.1     7.9     9.5     12.8    17.2    20.7    25.4    32.8    41.4    48.1    53.6    59.1    62.5    22.3[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Hodgkin lymphoma                                              0.2     0.3     0.3     0.3     0.3     0.4     0.3     0.3     0.4     0.4     0.4     0.4     0.5     0.5     5.0[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Non-Hodgkin lymphoma                                          4.5     4.2     4.5     4.6     4.9     5.3     5.3     5.5     5.6     5.7     6.2     6.2     6.5     6.6     3.6[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Multiple myeloma                                              1.0     1.0     1.1     1.1     1.1     1.2     1.3     1.3     1.4     1.4     1.5     1.5     1.4     1.6     3.7[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Leukemia                                                      4.7     4.3     4.7     4.8     4.8     4.8     4.7     4.9     4.8     5.0     5.1     5.0     5.2     4.9     0.9[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}
  Other and ill-defined                                         14.3    13.5    13.9    13.5    15.2    15.3    16.2    16.2    17.2    17.1    17.1    17.5    18.1    17.6    2.4[^a)^](#tfn13-crt-2015-060){ref-type="table-fn"}

APC, annual percentage change; CNS, central nervous system. APC was calculated using age-standardized incidence data based on the world standard population.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates in males from 1999 to 2012 in Korea

  Site/Type                                                     Year                                                                                                            
  ------------------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------------------------------------------------------
  All sites                                                     285.0   276.7   288.3   290.0   295.1   299.6   311.5   310.3   316.9   323.9   330.6   331.3   336.1   326.4   1.5[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Lip, oral cavity, and pharynx                                 6.1     7.1     6.0     6.2     6.5     6.2     6.1     6.2     6.3     6.5     6.1     6.1     6.3     6.1     -0.2
  Esophagus                                                     8.8     8.0     8.3     8.2     7.7     7.7     7.6     7.2     7.0     7.0     6.6     6.5     6.2     6.1     -2.6[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Stomach                                                       66.2    65.0    67.2    66.6    66.0    62.3    66.9    65.4    63.1    64.5    65.0    63.3    63.7    59.3    -0.5[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Colon and rectum                                              26.2    27.2    29.6    32.9    35.3    38.0    41.2    43.3    45.3    47.0    49.9    50.0    51.9    50.0    5.7[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Liver                                                         46.8    44.7    45.1    43.9    42.3    42.2    42.6    40.3    39.8    39.5    38.2    36.8    35.9    34.3    -2.1[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Gallbladder[^b)^](#tfn17-crt-2015-060){ref-type="table-fn"}   8.1     7.8     8.2     8.1     7.8     8.4     8.7     8.1     7.9     7.6     8.1     8.2     7.6     7.6     -0.3
  Pancreas                                                      7.8     7.6     7.6     7.9     7.7     8.0     8.3     8.0     8.2     8.4     8.1     8.0     8.6     8.4     0.8[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Larynx                                                        4.9     4.5     5.1     4.7     4.5     4.1     4.3     3.8     3.8     3.5     3.6     3.4     3.2     3.0     -3.7[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Lung                                                          51.4    49.8    51.1    51.0    50.0    50.8    50.9    49.2    48.7    47.6    47.5    47.5    46.4    44.3    -0.9[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Breast                                                        0.2     0.3     0.2     0.3     0.2     0.2     0.2     0.2     0.1     0.3     0.2     0.2     0.2     0.2     -1.1
  Prostate                                                      8.4     7.2     9.5     10.1    12.5    15.1    15.8    18.0    20.9    23.5    25.2    26.0    27.7    27.0    11.6[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Testis                                                        0.6     0.5     0.6     0.6     0.6     0.6     0.6     0.7     0.7     0.7     0.8     0.8     0.9     0.9     4.4[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Kidney                                                        4.5     4.4     4.9     5.0     5.2     5.5     6.0     6.5     7.1     7.4     7.6     8.0     8.2     8.2     5.5[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Bladder                                                       9.0     9.0     9.4     9.0     9.7     9.8     9.8     9.6     9.4     9.2     8.7     8.8     8.8     8.1     -0.6
  Brain and CNS                                                 3.2     3.1     3.1     2.9     3.3     3.3     3.3     3.2     3.4     3.4     3.5     3.5     3.0     3.3     0.6
  Thyroid                                                       2.1     1.9     2.4     2.7     3.7     4.8     5.9     7.5     10.0    13.3    15.6    18.6    20.4    23.0    23.6[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Hodgkin lymphoma                                              0.4     0.4     0.4     0.3     0.4     0.5     0.4     0.4     0.5     0.5     0.5     0.6     0.6     0.6     4.1[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Non-Hodgkin lymphoma                                          5.8     5.5     5.8     5.8     6.2     6.7     6.5     6.9     7.0     6.8     7.5     7.4     7.7     7.9     2.7[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Multiple myeloma                                              1.2     1.3     1.4     1.4     1.4     1.4     1.6     1.5     1.6     1.7     1.9     1.8     1.8     2.0     3.5[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Leukemia                                                      5.5     5.0     5.4     5.8     5.5     5.7     5.6     5.6     5.7     5.8     6.0     6.0     6.1     5.9     1.0[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}
  Other and ill-defined                                         17.9    16.5    16.8    16.5    18.5    18.3    19.3    18.9    20.3    19.8    20.0    19.8    20.8    20.1    1.7[^a)^](#tfn16-crt-2015-060){ref-type="table-fn"}

APC, annual percentage change; CNS, central nervous system. APC was calculated using age-standardized incidence data based on the world standard population.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates in females from 1999 to 2012 in Korea

  Site/Type                                                     Year                                                                                                            
  ------------------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------------------------------------------------------
  All sites                                                     161.1   157.4   169.0   174.6   184.5   193.6   208.0   216.6   232.3   249.6   263.6   274.8   289.3   290.1   5.3[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Lip, oral cavity, and pharynx                                 1.6     2.4     1.7     1.7     1.7     1.9     1.9     1.8     1.9     1.9     1.8     2.2     2.1     2.0     1.1
  Esophagus                                                     0.6     0.6     0.6     0.5     0.6     0.5     0.4     0.5     0.5     0.5     0.4     0.4     0.4     0.5     -2.2[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Stomach                                                       26.7    25.2    26.2    26.3    25.9    24.7    26.8    25.1    24.8    25.1    25.7    25.3    25.3    23.5    -0.5
  Colon and rectum                                              16.4    16.4    17.9    18.8    20.5    21.5    23.0    24.1    24.6    25.2    26.3    26.1    26.7    26.8    4.3[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Liver                                                         12.3    11.8    12.2    11.8    11.5    11.3    11.4    11.1    11.1    10.7    10.6    10.4    10.4    9.5     -1.6[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Gallbladder[^b)^](#tfn20-crt-2015-060){ref-type="table-fn"}   5.3     5.5     5.7     5.8     5.8     5.9     6.0     5.5     5.6     5.5     5.8     5.4     5.5     5.3     -0.2
  Pancreas                                                      4.0     4.0     4.0     4.2     4.5     4.5     4.7     4.7     4.8     4.9     4.9     5.0     5.1     5.4     2.3[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Larynx                                                        0.4     0.3     0.3     0.3     0.3     0.3     0.3     0.2     0.2     0.2     0.2     0.2     0.2     0.1     -7.5[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Lung                                                          12.4    12.5    12.3    12.6    12.4    13.0    13.5    14.0    14.0    14.2    14.2    14.7    15.3    14.9    1.7[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Breast                                                        20.9    20.9    24.7    27.2    27.9    29.4    32.0    33.3    35.7    37.2    38.8    40.7    44.0    44.7    6.1[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Cervix uteri                                                  16.3    15.1    15.8    14.8    14.2    13.1    12.4    12.2    11.1    11.5    10.7    10.9    10.2    9.5     -4.0[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Corpus uteri                                                  2.8     2.6     3.0     3.3     3.8     3.7     3.9     4.0     4.2     4.7     5.1     5.1     5.3     5.3     5.8[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Ovary                                                         5.0     4.8     4.8     5.0     5.1     5.2     5.4     5.4     5.9     5.6     5.4     5.9     5.8     6.0     1.7[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Kidney                                                        1.7     1.8     1.9     2.0     2.1     2.2     2.5     2.7     2.8     3.0     3.2     3.0     3.4     3.2     5.7[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Bladder                                                       1.6     1.6     1.7     1.7     1.8     1.7     1.7     1.6     1.7     1.6     1.6     1.5     1.5     1.4     -1.0
  Brain and CNS                                                 2.6     2.5     2.5     2.4     2.6     2.6     2.8     2.7     2.9     2.7     2.6     2.7     2.4     2.4     0.1
  Thyroid                                                       10.4    10.1    13.2    16.2    21.8    29.6    35.4    43.3    55.7    69.5    80.7    88.8    98.0    102.4   22.1[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Hodgkin lymphoma                                              0.1     0.2     0.2     0.2     0.2     0.2     0.2     0.3     0.3     0.3     0.3     0.3     0.4     0.3     6.0[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Non-Hodgkin lymphoma                                          3.4     3.2     3.4     3.5     4.0     4.1     4.4     4.4     4.4     4.8     5.1     5.2     5.6     5.6     4.5[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Multiple myeloma                                              0.8     0.8     0.9     0.8     1.0     1.0     1.2     1.1     1.2     1.2     1.2     1.3     1.1     1.4     4.1[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Leukemia                                                      3.9     3.8     4.1     4.0     4.1     4.1     4.0     4.4     4.2     4.3     4.2     4.1     4.5     4.1     0.7[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}
  Other and ill-defined                                         11.8    11.5    11.8    11.5    12.8    13.1    13.9    14.1    14.8    15.0    14.9    15.7    16.0    15.7    2.9[^a)^](#tfn19-crt-2015-060){ref-type="table-fn"}

APC, annual percentage change; CNS, central nervous system. APC was calculated using age-standardized incidence data based on the world standard population.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The five major sites of cancer incidence by age group and sex in Korea, 2012

  Rank     Age (yr)                                                                                            
  -------- --------------------------------------------------------- ---------------------- ------------------ ------------------
  Male                                                                                                         
   1       Leukemia                                                  Thyroid                Stomach            Lung
           (-4.8)                                                    (-15.4)                (-95.3)            (-441.3)
   2       Brain and CNS                                             Leukemia               Colon and rectum   Stomach
           (-2.4)                                                    (-3.1)                 (-77.1)            (-412.5)
   3       Non-Hodgkin lymphoma                                      Colon and rectum       Liver              Colon and rectum
           (-2.3)                                                    (-3.1)                 (-63.3)            (-354.9)
   4       Kidney                                                    Non-Hodgkin lymphoma   Thyroid            Prostate
           (-0.5)                                                    (-2.8)                 (-53.1)            (-293.7)
   5       Liver                                                     Stomach                Lung               Liver
           (-0.4)                                                    (-2.4)                 (-42.7)            (-202.8)
  Female                                                                                                       
   1       Leukemia                                                  Thyroid                Thyroid            Colon and rectum
           (-3.4)                                                    (-69.6)                (-246.2)           (-184.1)
   2       Non-Hodgkin lymphoma                                      Breast                 Breast             Stomach
           (-1.8)                                                    (-10.8)                (-119.3)           (-155.4)
   3       Brain and CNS                                             Cervix uteri           Colon and rectum   Lung
           (-1.7)                                                    (-5.2)                 (-45.3)            (-125.5)
   4       Ovary[^a)^](#tfn22-crt-2015-060){ref-type="table-fn"}     Stomach                Stomach            Thyroid
           (-0.9)                                                    (-3.8)                 (-39.7)            (-102.3)
   5       Thyroid[^a)^](#tfn22-crt-2015-060){ref-type="table-fn"}   Ovary                  Lung               Liver
           (-0.9)                                                    (-3.0)                 (-21.8)            (-71.8)

CNS, central nervous system.

The incidence rates of ovarian and thyroid cancer are the same in the 0-14 age group.

###### 

Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2012 in Korea

  Site/Type                                                     Both   Male   Female                                                                                   
  ------------------------------------------------------------- ------ ------ -------- ------- ------ ------ ------ ------ ------- ------ ------ ------ ------ ------- ------
  All sites                                                     41.2   44.0   53.8     68.1    26.9   31.7   35.3   45.3   59.6    27.9   53.4   55.3   64.0   76.6    23.2
  Lip, oral cavity, and pharynx                                 41.1   46.7   54.2     62.2    21.1   35.8   41.1   49.3   57.9    22.1   58.1   63.8   67.7   73.9    15.8
  Esophagus                                                     12.7   15.2   21.2     31.7    19.0   11.8   14.3   20.4   31.2    19.4   23.7   24.2   29.5   37.4    13.7
  Stomach                                                       42.8   46.6   57.7     71.5    28.7   43.0   46.9   58.4   72.2    29.2   42.6   46.0   56.4   70.0    27.4
  Colon and rectum                                              54.8   58.0   66.6     74.8    20.0   55.3   59.0   68.5   76.9    21.6   54.2   56.8   64.1   71.8    17.6
  Liver                                                         10.7   13.2   20.2     30.1    19.4   9.9    12.9   20.1   30.4    20.5   13.6   14.2   20.4   29.3    15.7
  Gallbladder[^b)^](#tfn25-crt-2015-060){ref-type="table-fn"}   17.3   19.7   22.8     28.3    11.0   16.6   20.3   23.4   29.5    12.9   18.0   19.1   22.3   27.2    9.2
  Pancreas                                                      9.4    7.6    8.1      8.8     -0.6   8.8    7.3    8.1    8.5     -0.3   10.1   8.1    8.1    9.3     -0.8
  Larynx                                                        59.7   62.3   66.1     73.4    13.7   60.2   62.8   66.8   73.6    13.4   55.4   57.8   58.2   69.6    14.2
  Lung                                                          11.3   12.7   16.2     21.9    10.6   10.4   11.6   15.0   19.4    9.0    14.2   16.2   19.7   28.2    14.0
  Breast                                                        77.9   83.2   88.5     91.3    13.4   75.1   85.6   87.0   90.0    14.9   78.0   83.2   88.5   91.3    13.3
  Cervix uteri                                                  77.5   80.0   81.3     80.3    2.8    \-     \-     \-     \-      \-     77.5   80.0   81.3   80.3    2.8
  Corpus uteri                                                  81.5   81.8   84.6     86.9    5.4    \-     \-     \-     \-      \-     81.5   81.8   84.6   86.9    5.4
  Ovary                                                         58.7   58.9   61.4     61.9    3.2    \-     \-     \-     \-      \-     58.7   58.9   61.4   61.9    3.2
  Prostate                                                      55.9   67.2   80.2     92.3    36.4   55.9   67.2   80.2   92.3    36.4   \-     \-     \-     \-      \-
  Testis                                                        85.4   90.4   90.6     94.2    8.8    85.4   90.4   90.6   94.2    8.8    \-     \-     \-     \-      \-
  Kidney                                                        62.0   66.1   73.4     79.9    17.9   60.8   64.4   72.8   79.4    18.6   64.5   69.7   74.5   81.0    16.5
  Bladder                                                       69.1   73.1   75.5     75.4    6.3    70.0   74.8   77.3   77.6    7.6    65.5   66.3   68.5   66.5    1.0
  Brain and CNS                                                 38.5   39.0   40.7     42.2    3.7    37.2   37.5   40.1   40.5    3.3    40.2   40.7   41.4   44.3    4.1
  Thyroid                                                       94.2   94.9   98.3     100.1   5.9    87.2   89.5   95.8   100.4   13.2   95.4   95.9   98.7   100.0   4.6
  Hodgkin lymphoma                                              68.0   71.2   76.6     82.6    14.6   67.6   68.1   74.6   82.1    14.5   68.6   77.4   80.6   83.5    14.9
  Non-Hodgkin lymphoma                                          46.6   50.8   59.9     67.5    20.9   45.3   48.9   58.1   65.6    20.3   48.7   53.5   62.4   69.7    21.0
  Multiple myeloma                                              22.1   19.8   29.3     36.4    14.3   21.1   17.8   29.6   35.8    14.7   23.3   22.1   28.9   37.1    13.8
  Leukemia                                                      26.5   33.3   41.8     48.9    22.4   26.2   32.3   41.6   48.8    22.6   26.8   34.6   42.0   49.2    22.4
  Other and ill-defined                                         42.1   45.9   55.9     67.3    25.2   37.4   42.4   52.2   63.7    26.3   47.4   50.0   59.9   71.0    23.6

CNS, central nervous system.

Percentage change in 5-year relative survival from 1993 to 1995 and 2008 to 2012,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized rates of cancer prevalence by sex on January 1, 2013 in Korea

  Site/Type                                                     Crude prevalence rate per 100,000[^a)^](#tfn27-crt-2015-060){ref-type="table-fn"}   Age-standardized prevalence rate per 100,000[^b)^](#tfn28-crt-2015-060){ref-type="table-fn"}                                 
  ------------------------------------------------------------- ----------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------- --------- --------- ---------
  All sites                                                     2,452.8                                                                             2,175.0                                                                                        2,730.9   1,649.2   1,592.2   1,788.0
  Lip, oral cavity, and pharynx                                 33.8                                                                                45.7                                                                                           22.0      23.0      33.2      14.3
  Esophagus                                                     14.8                                                                                26.7                                                                                           2.9       9.5       19.3      1.6
  Stomach                                                       411.4                                                                               546.5                                                                                          276.2     265.6     391.3     162.9
  Colon and rectum                                              344.5                                                                               410.9                                                                                          278.1     221.5     296.6     161.8
  Liver                                                         102.1                                                                               152.6                                                                                          51.5      68.8      109.7     32.3
  Gallbladder[^C)^](#tfn29-crt-2015-060){ref-type="table-fn"}   29.4                                                                                29.9                                                                                           28.8      18.4      21.6      16.0
  Pancreas                                                      14.0                                                                                15.1                                                                                           12.8      9.2       10.9      7.7
  Larynx                                                        17.1                                                                                32.1                                                                                           2.1       11.0      23.4      1.2
  Lung                                                          106.2                                                                               136.7                                                                                          75.8      68.3      99.1      44.8
  Breast                                                        262.5                                                                               2.2                                                                                            523.0     176.5     1.6       346.7
  Cervix uteri                                                  86.4                                                                                \-                                                                                             173.0     57.5      \-        111.7
  Corpus uteri                                                  30.2                                                                                \-                                                                                             60.4      20.6      \-        40.4
  Ovary                                                         28.1                                                                                \-                                                                                             56.3      20.3      \-        40.2
  Prostate                                                      97.3                                                                                194.6                                                                                          \-        58.4      141.6     \-
  Testis                                                        4.4                                                                                 8.8                                                                                            \-        4.0       7.8       \-
  Kidney                                                        51.7                                                                                69.7                                                                                           33.6      35.4      50.5      22.1
  Bladder                                                       50.6                                                                                82.4                                                                                           18.9      31.3      59.9      9.9
  Brain and CNS                                                 17.1                                                                                17.9                                                                                           16.4      15.0      16.0      13.9
  Thyroid                                                       514.0                                                                               162.5                                                                                          866.0     358.7     114.8     600.7
  Hodgkin lymphoma                                              4.0                                                                                 5.1                                                                                            2.9       3.4       4.3       2.5
  Non-Hodgkin lymphoma                                          52.5                                                                                56.8                                                                                           48.2      38.7      44.3      33.8
  Multiple myeloma                                              7.6                                                                                 8.1                                                                                            7.2       5.0       5.8       4.4
  Leukemia                                                      29.6                                                                                32.6                                                                                           26.5      28.4      31.8      25.1
  Other and ill-defined                                         143.4                                                                               138.4                                                                                          148.3     100.5     108.6     93.9

CNS, central nervous system.

Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation; Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2012 and who were alive on January 1, 2013; Multiple primary cancer cases were counted multiple times,

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.
